Jonathon Alexis Coates

1.8k total citations · 1 hit paper
13 papers, 1.2k citations indexed

About

Jonathon Alexis Coates is a scholar working on Infectious Diseases, Epidemiology and Immunology. According to data from OpenAlex, Jonathon Alexis Coates has authored 13 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Infectious Diseases, 4 papers in Epidemiology and 4 papers in Immunology. Recurrent topics in Jonathon Alexis Coates's work include HIV Research and Treatment (3 papers), HIV/AIDS drug development and treatment (3 papers) and Academic Publishing and Open Access (2 papers). Jonathon Alexis Coates is often cited by papers focused on HIV Research and Treatment (3 papers), HIV/AIDS drug development and treatment (3 papers) and Academic Publishing and Open Access (2 papers). Jonathon Alexis Coates collaborates with scholars based in United Kingdom, Germany and Australia. Jonathon Alexis Coates's co-authors include J. M. Cameron, N. Cammack, Charles R. Penn, Máté Pálfy, Jessica Polka, G.K. Dey, Liam Brierley, Federico Nanni, Nicholas Fraser and Ian M. Mutton and has published in prestigious journals such as Nature Communications, Scientific Reports and PLoS Biology.

In The Last Decade

Jonathon Alexis Coates

13 papers receiving 1.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The evolving role of preprints in the dissemination of COVID-19 research and their impact on the science communication landscape

2021 239 citations Nicholas Fraser, Liam Brierley et al. PLoS Biology profile →

Peers

Countries citing papers authored by Jonathon Alexis Coates

Since Specialization

Citations

This map shows the geographic impact of Jonathon Alexis Coates's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathon Alexis Coates with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathon Alexis Coates more than expected).

Fields of papers citing papers by Jonathon Alexis Coates

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jonathon Alexis Coates. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathon Alexis Coates. The network helps show where Jonathon Alexis Coates may publish in the future.

Co-authorship network of co-authors of Jonathon Alexis Coates

This figure shows the co-authorship network connecting the top 25 collaborators of Jonathon Alexis Coates. A scholar is included among the top collaborators of Jonathon Alexis Coates based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jonathon Alexis Coates. Jonathon Alexis Coates is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

#	Work	Indexed citations
1	Tracking changes between preprint posting and journal publication during a pandemic 2022 ·PLoS Biology ·Liam Brierley, Federico Nanni, Jessica Polka, G.K. Dey, Máté Pálfy, Nicholas Fraser, Jonathon Alexis Coates	54
2	Neutrophil breaching of the blood vessel pericyte layer during diapedesis requires mast cell-derived IL-17A 2022 ·Nature Communications ·Régis Joulia, (unknown), Tamara Girbl, Jonathon Alexis Coates, (unknown), (unknown), Eleanor Lynam, James R. Whiteford, Michael Schnoor, David Voehringer, Axel Roers, Sussan Nourshargh, Mathieu-Benoı̂t Voisin	20
3	Identification of functionally distinct macrophage subpopulations in Drosophila 2021 ·eLife ·Jonathon Alexis Coates, Elliot Brooks, Amy Brittle, Emma Louise Armitage, Martin P. Zeidler, Iwan R. Evans	18
4	The evolving role of preprints in the dissemination of COVID-19 research and their impact on the science communication landscape breakdown → 2021 ·PLoS Biology ·Nicholas Fraser, Liam Brierley, G.K. Dey, Jessica Polka, Máté Pálfy, Federico Nanni, Jonathon Alexis Coates	239
5	Simu-dependent clearance of dying cells regulates macrophage function and inflammation resolution 2019 ·PLoS Biology ·Hannah Roddie, Emma Louise Armitage, Jonathon Alexis Coates, Simon A. Johnston, Iwan R. Evans	18
6	A potential mode of action for Anakinra in patients with arthrofibrosis following total knee arthroplasty 2015 ·Scientific Reports ·David Dixon, Jonathon Alexis Coates, (unknown), (unknown), (unknown), (unknown), Nicholas S. Kalson, N Brewster, David J. Weir, David J. Deehan, Derek A. Mann, Lee A. Borthwick	26
7	BET 1: Levosimendan in septic shock 2014 ·Emergency Medicine Journal ·Jonathon Alexis Coates, (unknown)	2
8	Globoidnan A: a lignan from inhibits HIV integrase 2004 ·Phytochemistry ·Simon P. B. Ovenden, John Yu, (unknown), Gian Sberna, (unknown), David Rhodes, Selina Cox, Jonathon Alexis Coates, Nicole C. Walsh, Barbara Meurer‐Grimes	42
9	Incursion of epizootic hemorrhagic disease into the Okanagan Valley, British Columbia in 1999. 2001 ·PubMed ·John Pasick, (unknown), En‐Min Zhou, (unknown), Jonathon Alexis Coates, Y. Robinson, (unknown)	9
10	Susceptibility in cell culture of feline immunodeficiency virus to eighteen antiviral agents 1994 ·Journal of Antimicrobial Chemotherapy ·Neil Smyth, (unknown), R. M. Gaskell, J. M. Cameron, Jonathon Alexis Coates, C. J. Gaskell, C. A. Hart, Malcolm J. Bennett	15
11	4-Guanidino-2,4-dideoxy-2,3-dehydro-N-acetylneuraminic acid is a highly effective inhibitor both of the sialidase (neuraminidase) and of growth of a wide range of influenza A and B viruses in vitro 1993 ·Antimicrobial Agents and Chemotherapy ·(unknown), Richard C. Bethell, Jonathon Alexis Coates, (unknown), (unknown), (unknown), David Ryan, John R. Ticehurst, (unknown), Sarah M. Walcott	253
12	(-)-2'-deoxy-3'-thiacytidine is a potent, highly selective inhibitor of human immunodeficiency virus type 1 and type 2 replication in vitro 1992 ·Antimicrobial Agents and Chemotherapy ·Jonathon Alexis Coates, N. Cammack, (unknown), Amanda Jowett, (unknown), (unknown), Charles R. Penn, (unknown), (unknown), J. M. Cameron	216
13	The separated enantiomers of 2'-deoxy-3'-thiacytidine (BCH 189) both inhibit human immunodeficiency virus replication in vitro 1992 ·Antimicrobial Agents and Chemotherapy ·Jonathon Alexis Coates, N. Cammack, (unknown), Ian M. Mutton, (unknown), Richard Storer, J. M. Cameron, Charles R. Penn	252

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact